SCFD1 and amyotrophic lateral sclerosis: Positive correlations between the expression of G2E3 and SCFD1 were identified in both the ALS diseased group (Spearman ρ [95% CI] = 0.41 [0.27-0.54], P = 4.1×10-8;Fig. 3E) and the control group (Spearman ρ [95% CI] = 0.41 [0.27-0.54], P = 4.9×10-2;Fig. 3E).